Skip to main content

Sloan-Kettering Institute Licenses GeneBio's Phenyx Software

NEW YORK (GenomeWeb News) – The Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed Geneva Bioinformatics’ PhenyxServer protein identification and characterization software, GeneBio said today.
 
Under the agreement, Sloan-Kettering researcher Paul Tempst will use the Phenyx protein identification and characterization software in its Clinical Proteomic Technology Assessment for Cancer group.
 
The Phenyx identification and characterization software platform, which was developed through a partnership with the Swiss Institute of Bioinformatics, includes protein searches and comparison and quantitation of multiple results.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.